AUAUniversity Podcast Series: Episode No.338

LG-IR-NMIBC Treatment Landscape

Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Chad R. Ritch, MD, MBA, FACS

CME Available: auau.auanet.org/node/44036

ACKNOWLEDGEMENTS:
Support provided by independent educational grants from:
AstraZeneca
Johnson & Johnson

LEARNING OBJECTIVES:
At the conclusion of this activity, participants will be able to:
1. Differentiate between traditional and emerging intravesical therapies for LG-IR-NMIBC, considering mechanism of action, administration schedules, and patient eligibility to support individualized treatment planning.
2. Incorporate into practice shared decision-making strategies that align clinical recommendations with patient values, preferences, and quality-of-life considerations in the management of LG-IR-NMIBC.
3. Utilize practical approaches for integrating intravesical therapy into routine clinical workflows, including coordination among multidisciplinary teams, patient education, and follow-up to optimize adherence and outcomes.